A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

June 30, 2008

Conditions
Gastric Cancer
Interventions
DRUG

docetaxel, oxaliplatin

"Oxaliplatin will be administered in combination with docetaxel as a first-line chemotherapy in advanced gastric cancer patients. Each cycle is repeated every 3 weeks.~Docetaxel Oxaliplatin Level 1 60 mg/m2/day 1 100 mg/m2/day 1 Level 2 75 mg/m2/day 1 100 mg/m2/day 1 Level 3 75 mg/m2/day 1 130 mg/m2/day 1"

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00533533 - A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter